London
· Delayed Price · Currency is GBP · Price in GBX Genflow Biosciences Statistics
Total Valuation
LON:GENF has a market cap or net worth of GBP 6.64 million. The enterprise value is 5.50 million.
| Market Cap | 6.64M |
| Enterprise Value | 5.50M |
Important Dates
The next estimated earnings date is Tuesday, April 29, 2025.
| Earnings Date | Apr 29, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
LON:GENF has 349.71 million shares outstanding. The number of shares has increased by 3.90% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 349.71M |
| Shares Change (YoY) | +3.90% |
| Shares Change (QoQ) | +8.74% |
| Owned by Insiders (%) | 52.02% |
| Owned by Institutions (%) | 22.60% |
| Float | 161.13M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 9.70 |
| PB Ratio | 7.74 |
| P/TBV Ratio | 7.74 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -3.59 |
| EV / Sales | 9.20 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -5.46 |
Financial Position
The company has a current ratio of 2.73
| Current Ratio | 2.73 |
| Quick Ratio | 2.41 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -118.87% and return on invested capital (ROIC) is -74.30%.
| Return on Equity (ROE) | -118.87% |
| Return on Assets (ROA) | -58.66% |
| Return on Invested Capital (ROIC) | -74.30% |
| Return on Capital Employed (ROCE) | -178.43% |
| Revenue Per Employee | 119,608 |
| Profits Per Employee | -306,285 |
| Employee Count | 5 |
| Asset Turnover | 0.37 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +37.93% in the last 52 weeks. The beta is 2.35, so LON:GENF's price volatility has been higher than the market average.
| Beta (5Y) | 2.35 |
| 52-Week Price Change | +37.93% |
| 50-Day Moving Average | 1.88 |
| 200-Day Moving Average | 2.11 |
| Relative Strength Index (RSI) | 46.81 |
| Average Volume (20 Days) | 639,505 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, LON:GENF had revenue of GBP 598,041 and -1.53 million in losses. Loss per share was -0.01.
| Revenue | 598,041 |
| Gross Profit | 598,041 |
| Operating Income | -1.53M |
| Pretax Income | -1.53M |
| Net Income | -1.53M |
| EBITDA | -1.53M |
| EBIT | -1.53M |
| Loss Per Share | -0.01 |
Balance Sheet
| Cash & Cash Equivalents | 1.14M |
| Total Debt | n/a |
| Net Cash | 1.14M |
| Net Cash Per Share | 0.00 |
| Equity (Book Value) | 858,345 |
| Book Value Per Share | 0.00 |
| Working Capital | 854,889 |
Cash Flow
In the last 12 months, operating cash flow was -1.01 million and capital expenditures 1,346, giving a free cash flow of -1.01 million.
| Operating Cash Flow | -1.01M |
| Capital Expenditures | 1,346 |
| Free Cash Flow | -1.01M |
| FCF Per Share | -0.00 |
Margins
Gross margin is 100.00%, with operating and profit margins of -256.10% and -256.07%.
| Gross Margin | 100.00% |
| Operating Margin | -256.10% |
| Pretax Margin | -256.07% |
| Profit Margin | -256.07% |
| EBITDA Margin | -255.89% |
| EBIT Margin | -256.10% |
| FCF Margin | n/a |
Dividends & Yields
LON:GENF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.90% |
| Shareholder Yield | -3.90% |
| Earnings Yield | -23.05% |
| FCF Yield | -15.18% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
LON:GENF has an Altman Z-Score of 0.21. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.21 |
| Piotroski F-Score | n/a |